Streetbeat News

Revenues

AOS

A.O. Smith (NYSE:AOS) reported Q2 2024 earnings per share (EPS) of $1.06, which met analyst expectations. The company also reported sales of $1.024 billion, surpassing the analyst estimate of $997.753 million. This represents a 4.95% increase in EPS and a 6.58% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 10:58 am

KO

Coca-Cola projects a 9-10% growth in organic revenue for FY24, but expects an 8-9% currency headwind to impact comparable EPS growth.

Portfolio Pulse from Bill Haddad

July 23, 2024 | 10:57 am

DGX

Quest Diagnostics has updated its 2024 net revenue forecast to a range of $9.5 billion to $9.58 billion, which is higher than its previous guidance of $9.4 billion to $9.48 billion and above the consensus estimate of $9.46 billion.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 10:57 am

PNR

Pentair (NYSE:PNR) reported Q2 2024 adjusted EPS of $1.22, beating the estimate of $1.14. Sales were $1.099 billion, surpassing the $1.095 billion estimate. This represents a 1.57% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 10:56 am

KO

Coca-Cola (NYSE:KO) reported Q2 2024 earnings of $0.84 per share, beating the analyst estimate of $0.81. The company also reported sales of $12.4 billion, surpassing the $11.753 billion estimate. This represents a 3.58% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 10:55 am

CBU

Community Financial (NYSE:CBU) reported Q2 2024 adjusted EPS of $0.95, beating the $0.81 estimate. Sales were $183.799M, surpassing the $179.556M estimate and showing a 4.87% increase from last year's $175.263M.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 10:49 am

MEDP

Medpace Holdings shares are trading lower after the company reported mixed Q2 financial results and narrowed its FY24 revenue guidance with its midpoint below estimates.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 10:48 am

MSCI

MSCI has reiterated its full-year 2024 guidance, including capital expenditures of $95M-$105M and free cash flow of $1.225B-$1.285B. The guidance is based on various macroeconomic assumptions and is subject to uncertainties.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 10:47 am

DGX

Quest Diagnostics reported Q2 2024 adjusted EPS of $2.35, beating the estimate of $2.34. Sales were $2.397 billion, also surpassing the estimate of $2.390 billion.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 10:47 am

AVY

Avery Dennison (NYSE:AVY) reported Q2 earnings of $2.42 per share, beating the analyst estimate of $2.26. Sales were $2.23 billion, surpassing the $2.18 billion estimate. Both earnings and sales showed significant year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 10:46 am